1. Genetics of osteonecrosis in children and adults with systemic lupus erythematosus.
- Author
-
Webber, Declan, Cao, Jingjing, Dominguez, Daniela, Gladman, Dafna D, Knight, Andrea, Levy, Deborah M, Liao, Fangming, Ng, Lawrence, Paterson, Andrew D, Touma, Zahi, Wither, Joan, Urowitz, Murray, Silverman, Earl D, and Hiraki, Linda T
- Subjects
- *
SYSTEMIC lupus erythematosus diagnosis , *OSTEONECROSIS , *ADRENOCORTICAL hormones , *CONFIDENCE intervals , *SINGLE nucleotide polymorphisms , *AGE distribution , *GENETIC variation , *TERTIARY care , *RISK assessment , *GENOME-wide association studies , *SEX distribution , *AGE factors in disease , *GENOTYPES , *FACTOR analysis , *DESCRIPTIVE statistics , *SYSTEMIC lupus erythematosus , *LOGISTIC regression analysis , *DISEASE risk factors , *DISEASE complications - Abstract
Objectives Genetics plays an important role in SLE risk, as well as osteonecrosis (ON), a significant and often debilitating complication of SLE. We aimed to identify genetic risk loci for ON in people with childhood-onset (cSLE) and adult-onset (aSLE) SLE. Methods We enrolled participants from two tertiary care centres who met classification criteria for SLE. Participants had prospectively collected clinical data and were genotyped on a multiethnic array. Un-genotyped single nucleotide polymorphisms (SNPs) were imputed, and ancestry was inferred using principal components (PCs). Our outcome was symptomatic ON confirmed by imaging. We completed time-to-ON and logistic regression of ON genome-wide association studies (GWASs) with covariates for sex, age of SLE diagnosis, five PCs for ancestry, corticosteroid use and selected SLE manifestations. We conducted separate analyses for cSLE and aSLE and meta-analysed results using inverse-variance weighting. Genome-wide significance was P < 5 × 10−8. Results The study included 940 participants with SLE, 87% female and 56% with cSLE. ON was present in 7.6% (n = 71). Median age of SLE diagnosis was 16.9 years (interquartile range [IQR]: 13.5, 29.3), with median follow-up of 8.0 years (IQR: 4.2, 15.7). Meta-GWAS of cSLE and aSLE time-to-ON of 4 431 911 SNPs identified a significant Chr.2 SNP, rs34118383 (minor allele frequency = 0.18), intronic to WIPF1 (hazard ratio = 3.2 [95% CI: 2.2, 4.8]; P = 1.0 × 10−8). Conclusion We identified an intronic WIPF1 variant associated with a 3.2 times increased hazard for ON (95% CI: 2.2, 4.8; P = 1.0 × 10−8) during SLE follow-up, independent of corticosteroid exposure. The effect of the SNP on time-to-ON was similar in cSLE and aSLE. This novel discovery represents a potential ON risk locus. Our results warrant replication. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF